华法林与低分子肝素预防血栓的临床疗效

Clinical efficacy of warfarin combined with low molecular weight heparin in preventing thromboembolism

目的:探究华法林与低分子肝素在血栓预防中的应用效果。方法:收治外科手术患者40例。随机平分两组。对照组采用常规治疗方法;观察组在患者术后1~3 d,在常规治疗的基础上,采用华法林联合低分子肝素进行血栓预防。对两组患者血栓形成情况进行统计和分析。结果:观察组血栓形成概率低于对照组(P<0.05)。结论:对于外科术后患者,采用华法林与低分子肝素预防血栓,能够获得较好的预防效果。

Objective:To investigate the clinical efficacy of warfarin combined with low molecular weight heparin in preventingthromboembolism.Methods:40patients with surgical operation were selected.They were randomly divided into the two groups onaverage.The control group was treated with conventional treatment.After surgery for1～3days,on the basis of conventionaltreatment,the observation group used warfarin combined with low molecular weight heparin in thrombosis prevention.Thethrombosis situations of the two groups were statistically counted and analyzed.Results:The incidence of thrombosis in observationgroup was lower than that in the control group(P<0.05).Conclusion:For patients after surgery,warfarin and low molecular weightheparin to prevent thrombosis can obtain good preventive effect.